Decibel Therapeutics (DBTX) has a profit margin of -Infinity%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2023
Trailing 12 months ending Jun 2023
As of the most recent data (June 2023), DBTX shows a profit margin of -Infinity%. That is below the Healthcare sector average of 15.58%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average profit margin is about 15.58%. Decibel Therapeutics is at -Infinity%, which is lower that average. That is roughly Infinity% below the sector mean. Use the comparison chart on this page to see how DBTX stacks up against individual peers as well.
Check the historical chart to see whether DBTX's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Decibel Therapeutics with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Decibel Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -Infinity%) with ownership activity and broader fundamentals.
The Healthcare average profit margin is about 15.58%, while DBTX is at -Infinity%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.